Aligos Therapeutics Inc (ALGS) Insider Trading
Total insider buys:
- $17,279,536.76
Total insider sells:
- $0.00
Most recent insider trade:
- Oct. 25, 2023
Most active insider trader:
- Carole Nuechterlein
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Oct. 25, 2023 | Director | 7,933,601 | $0.76 | Buy | $6,029,536.76 | |
| Oct. 20, 2020 | Director | 200,000 | $15.00 | Buy | $3,000,000.00 | |
| Oct. 20, 2020 | Major Shareholder | 550,000 | $15.00 | Buy | $8,250,000.00 |
First«1 of 1»Last
Insiders are buying Aligos Therapeutics Inc stock.
The insider traders at Aligos Therapeutics Inc are: Carole Nuechterlein, Thomas Woiwode, and Vivo Capital Fund Viii, L.P.
The most active insider trader at Aligos Therapeutics Inc is Carole Nuechterlein with 1 trades.
Vivo Capital Fund Viii, L.P. has bought the most Aligos Therapeutics Inc stock with a total value of $16,500,000.00.
The most recent insider trade for Aligos Therapeutics Inc was on Oct. 25, 2023.
The single biggest insider buy for Aligos Therapeutics Inc was from Vivo Capital Fund Viii, L.P. with a total value of $8,250,000.00 on Oct. 20, 2020.